Cannabidiol clinical trials at University of California Health

11 in progress, 8 open to eligible people

Showing trials for

  • Hemp-Derived, High Cannabidiol Product for Anxiety in Glioblastoma Patients

    open to eligible people ages 18 years and up

    Glioblastoma (GBM) is the most common malignant brain tumor among adults. As the diagnosis is generally considered terminal, patients with GBM often suffer from anxiety and other comorbid conditions, including depression, pain, and sleep…

    at UCSF

  • Cannabidiol and Prolonged Exposure

    open to eligible people ages 18 years and up

    The trial will include a randomized control trial to evaluate the efficacy of using Cannabidiol (CBD), a non-intoxicating cannabinoid, as an adjunctive to Prolonged Exposure therapy (PE). The trial will compare PE + CBD to PE + placebo in a sample…

    at UCSD

  • Cannabidiol for Reducing Cigarette Use

    open to eligible people ages 18-65

    The goal of this research is to evaluate the efficacy of cannabidiol (CBD) in reducing cigarette smoking. Although there are safe and effective treatments for smoking cessation, not everyone who attempts smoking cessation is successful, even with…

    at UCLA

  • Cannabis Use, Cognition, and the Endocannabinoid System in HIV

    open to eligible people ages 18-65

    Understanding how co-morbidities in persons with HIV (PWH) such as substance use affect risk-taking, decision-making, and other cognitive behaviors is important given implications for everyday functioning and transmission risk. The high prevalence…

    at UCSD

  • Cannabidiol (CBD) Versus Placebo as an Adjunct to Treatment in Early Psychosis

    open to eligible people ages 16-30

    This is an outpatient, single center, between-group, double blind, placebo controlled design. Approximately 120 adolescents and adult patients will be randomized to either have their treatment augmented with Cannabidiol Oral Solution (CBD) or with a …

    at UCSD

  • Cannabidiol and Tetrahydrocannabinol on Microbiome and Neuroinflammation in HIV

    open to eligible people ages 21-70

    This study has the potential to contribute to a more complete understanding of the independent and combined effects of cannabis use and HIV on the brain and on inflammation. Such knowledge may inform future strategies for treating brain disease and…

    at UCSD

  • Cannabidiol in Children, Adolescents, and Young Adults with Fragile X Syndrome

    “Children and teens between 3 and 17 diagnosed with Fragile X syndrome may qualify for a clinical trial”

    open to eligible people ages 3-29

    This is a randomized, double-blind, placebo-controlled, multiple-center study, to assess the efficacy and safety of Cannabidiol administered as ZYN002 for the treatment of children, adolescent, and young adult patients with Fragile X Syndrome (FXS). …

    at UC Davis

  • Role of CBD in Improving Alexithymia

    open to eligible people ages 21 years and up

    Given the treatments that are available today for HIV disease, people living with HIV (PLWH) can generally expect good medical outcomes. However, HIV is still a chronic disease and there are remaining barriers to achieving ideal health status and…

    at UCSD

  • Extension to Assess the Long-Term Safety and Tolerability of ZYN002 in Children and Adolescents With FXS

    Sorry, accepting new patients by invitation only

    ZYN002 is a pharmaceutically manufactured Cannabidiol that is developed as a clear gel that can be applied to the skin (called transdermal delivery). The gel will be applied to clean, dry, intact skin of the shoulders and/or upper arms. Participants …

    at UC Davis

  • Role of CBD in Regulating Meal Time Anxiety in Anorexia Nervosa

    Sorry, in progress, not accepting new patients

    No studies of cannabidiol (CBD) have focused on Anorexia Nervosa (AN). Dose, side effects, tolerability, acceptability of pure CBD in AN must be established. The current study is an important first step in the investigation of CBD for AN. Cannabis…

    at UCSD

  • Cannabidiol in Sanfilippo Syndrome

    Sorry, not yet accepting patients

    The goal of this clinical trial is to test cannabidiol in Sanfilippo syndrome. The main questions it aims to answer are: 1) determine the safety of cannabidiol in Sanfilippo syndrome, and 2) explore the efficacy of cannabidiol in treating the…

    at UCLA

Our lead scientists for Cannabidiol research studies include .

Last updated: